Cancer journal (Sudbury, Mass.)

publication venue for

Smoldering Myeloma Treatment: Who, What, and When.. 27. 2021
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients.. 22. 2016
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States.. 20. 2014
Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.. 20. 2014
Breast reconstruction combined with radiation therapy: long-term risks and factors related to decision making.. 14. 2008
Breast reconstruction with prosthetic implants.. 14. 2008
Nipple areola reconstruction.. 14. 2008
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer.. 12. 2006
The interactions of polarographic measurements of oxygen tension and histological grade in human glioma.. 12. 2006
A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.. 11. 2005
Is there an optimal hemoglobin level for patients with glioblastoma multiforme?. 10. 2004
Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy, and surgery.. 9. 2003
Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.. 9. 2003
Thallium-201 imaging in evaluation of Hodgkin's disease.. 8. 2002
The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?. 8. 2002
Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.. 8. 2002
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.. 8. 2002
Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival.. 6. 2000
Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence.. 6. 2000
Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.. 6. 2000
A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.. 6. 2000
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.. 6. 2000
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.. 6. 2000
Chimeric Antigen Receptor-Modified Immune Effector Cell Therapies: Learning From the Present; Charting a Path to the Future.. 27. 2021
From the guest editor: The rise of CAR therapy: the CD19 paradigm, and beyond. Introduction.. 20. 2014
More than 200,000 women will be diagnosed with breast cancer in 2008.. 14. 2008
Central Nervous System Lymphoma: Approach to Diagnosis and Treatment. 2020
HIV Lymphoma and Burkitts Lymphoma. 2020
Clinical Development of PD-1 Blockade in Hematologic Malignancies. 2018
Clinical Development of PD-1 in Advanced Melanoma. 2018
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation. 2017
Advances in Interventional Oncology: Lung Cancer. 2016
The Importance of Biopsy in the Era of Molecular Medicine. 2016
Immune Therapy for Prostate Cancer. 2016
Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer. 2016
Value in Colorectal Cancer Treatment: Where It Is Lacking, and Why. 2016
Immune Checkpoint Therapy in Renal Cell Carcinoma. 2016
Novel Approaches to Imaging Tumor Metabolism. 2015
CD28z CARs and armored CARs. 2014
Genetics of myeloproliferative neoplasms. 2014
Androgen receptor antagonists in castration-resistant prostate cancer. 2013
Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers. 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long. 2012
Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanoma. 2012
Therapeutic implications of KIT in melanoma. 2012
Circulating tumors cells as biomarkers: progress toward biomarker qualification. 2011
Prognostic determinants in prostate cancer. 2011
Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy. 2011
Lung cancer vaccines. 2011
Immune regulatory antibodies: are they the next advance? 2010
Implanted hepatic arterial infusion pumps. 2010
Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. 2010
T-cell engineering for cancer immunotherapy. 2009
Role of radiation therapy in Hodgkin's lymphoma. 2009
Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. 2008
Pitfalls or promise in prostate cancer immunotherapy-which is winning? 2008
Promising new therapies for malignant gliomas. 2007
Adjuvant therapy of colon cancer: current status and future directions. 2007
Adjuvant therapy of melanoma. 2007
Esophageal cancer: adjuvant therapy. 2007
Systemic or regional chemotherapy for liver metastases from colorectal cancer: has the wheel stopped spinning? 2004
Radiofrequency ablation of early-stage invasive breast tumors: an overview. 2002
Radiofrequency ablation of solid tumors. 2001
Multimodality therapy of esophageal cancer: an update. 2000
Therapeutic implications of the new biology. 2000
Radiopharmaceuticals for Cancer Diagnosis and Therapy: New Targets, New Therapies-Alpha-Emitters, Novel Targets. 2024
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease. 2024
Neurotoxicity Biology and Management. 2021
Molecular Diagnostics of Non-Hodgkin Lymphoma. 2020
Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma. 2016
CD19-Targeted T Cells for Hematologic Malignancies: Clinical Experience to Date. 2015
Challenges of Pancreatic Cancer. 2015
Molecular diagnostics of T-cell lymphoproliferative disorders. 2014
Novel approaches targeting the vascular endothelial growth factor axis in renal cell carcinoma. 2013
Robotic surgery: colon and rectum. 2013
Causes and consequences of microRNA dysregulation. 2012
Triple-negative breast cancer: role of the androgen receptor. 2010
Novel immunotherapies. 2009
An update on the treatment of CNS metastases in small cell lung cancer. 2008
Survivorship after childhood, adolescent, and young adult cancer. 2008
Breast cancer adjuvant endocrine therapy. 2007
CT screening for lung cancer: the first ten years. 2002

VIVO Weill Cornell Medical College

Cancer journal (Sudbury, Mass.) Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)